EA199700265A1 - Добавочный протеин рецептора интерлейкина-1 человека - Google Patents
Добавочный протеин рецептора интерлейкина-1 человекаInfo
- Publication number
- EA199700265A1 EA199700265A1 EA199700265A EA199700265A EA199700265A1 EA 199700265 A1 EA199700265 A1 EA 199700265A1 EA 199700265 A EA199700265 A EA 199700265A EA 199700265 A EA199700265 A EA 199700265A EA 199700265 A1 EA199700265 A1 EA 199700265A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- receptor
- additional
- human interleukin
- additional protein
- receptor protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37626895A | 1995-01-23 | 1995-01-23 | |
PCT/EP1996/000181 WO1996023067A1 (fr) | 1995-01-23 | 1996-01-17 | Proteine accessoire humaine du recepteur de l'interleukine-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA199700265A1 true EA199700265A1 (ru) | 1998-04-30 |
Family
ID=23484321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA199700265A EA199700265A1 (ru) | 1995-01-23 | 1996-01-17 | Добавочный протеин рецептора интерлейкина-1 человека |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0808365A1 (fr) |
JP (1) | JPH10512453A (fr) |
AR (1) | AR003919A1 (fr) |
AU (1) | AU4537096A (fr) |
BR (1) | BR9606837A (fr) |
CA (1) | CA2210724A1 (fr) |
CO (1) | CO4480033A1 (fr) |
CZ (1) | CZ208197A3 (fr) |
EA (1) | EA199700265A1 (fr) |
FI (1) | FI973089A0 (fr) |
HU (1) | HUP9702458A2 (fr) |
IL (1) | IL116796A0 (fr) |
MX (1) | MX9705501A (fr) |
NO (1) | NO973404L (fr) |
PE (1) | PE64396A1 (fr) |
PL (1) | PL321538A1 (fr) |
TR (1) | TR199700652T1 (fr) |
WO (1) | WO1996023067A1 (fr) |
ZA (1) | ZA96333B (fr) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7011696A (en) * | 1996-08-26 | 1998-03-19 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
US6974682B1 (en) | 1996-08-26 | 2005-12-13 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
DE69738948D1 (de) | 1996-12-06 | 2008-10-09 | Amgen Inc | Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
EP0979282A1 (fr) | 1997-04-30 | 2000-02-16 | F. Hoffmann-La Roche Ag | Chemokine st38.2 du rat |
US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
AU755391B2 (en) | 1997-12-23 | 2002-12-12 | Immunex Corporation | SIGIRR DNA and polypeptides |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
US7049095B2 (en) | 2000-10-31 | 2006-05-23 | Immunex Corporation | DNA encoding IL-1 receptor accessory protein |
GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
PT2087908T (pt) | 2001-06-26 | 2018-07-16 | Amgen Inc | Anticorpos contra opgl |
KR100453877B1 (ko) | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체 |
EP1450837A4 (fr) * | 2001-08-07 | 2006-01-04 | Immunex Corp | Recepteurs de l'interleukine-1 dans le traitement de maladies |
NZ605429A (en) | 2002-09-06 | 2014-08-29 | Amgen Inc | Therapeutic human anti-il-1r1 monoclonal antibody |
CA2557910C (fr) | 2004-04-02 | 2012-05-29 | Amgen Inc. | Procedes de reduction de l'agregation d'un antagoniste du recepteur de l'il-1 |
US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
WO2005105830A1 (fr) * | 2004-05-05 | 2005-11-10 | Valorisation-Recherche, Societe En Commandite | Antagonistes du recepteur de l'interleukine-1, compositions, et methodes de traitement |
EP2366786A3 (fr) * | 2005-05-05 | 2012-08-29 | VALORISATION HSJ, Société en Commandite | Modulateurs de récepteur de cytokine et utilisations associées |
PE20070684A1 (es) | 2005-11-14 | 2007-08-06 | Amgen Inc | MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP |
JP2011515497A (ja) | 2008-03-26 | 2011-05-19 | セレラント セラピューティクス インコーポレイテッド | 骨髄性血液学的増殖性疾患と関連する免疫グロブリンおよび/またはToll様受容体タンパク質ならびにその使用 |
EP2196476A1 (fr) | 2008-12-10 | 2010-06-16 | Novartis Ag | Formulation d'anticorps |
GB2472856B (en) * | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CN107929730A (zh) | 2011-01-19 | 2018-04-20 | 坎塔吉亚有限责任公司 | 抗il1rap抗体及其治疗人类的用途 |
WO2012177595A1 (fr) * | 2011-06-21 | 2012-12-27 | Oncofactor Corporation | Compositions et méthodes pour la thérapie et le diagnostic du cancer |
US8841418B2 (en) | 2011-07-01 | 2014-09-23 | Cellerant Therapeutics, Inc. | Antibodies that specifically bind to TIM3 |
GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
WO2016183106A1 (fr) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Procédés et compositions pour la détermination de la ploïdie |
JP7114460B2 (ja) | 2015-06-26 | 2022-08-08 | サノフィ・バイオテクノロジー | モノクローナル抗IL-1RAcP抗体 |
EP3241845A1 (fr) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Anticorps anti-il-1r3 humanisés |
WO2018022982A1 (fr) | 2016-07-29 | 2018-02-01 | Trustees Of Boston University | L'hématopoïèse clonale associée à l'âge accélère le développement d'une maladie cardio-métabolique |
EP3401332A1 (fr) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anticorps anti-il-1r3 destinés à être utilisés dans des conditions inflammatoires |
JP2020524519A (ja) | 2017-06-20 | 2020-08-20 | ザ メディカル カレッジ オブ ウィスコンシン,インコーポレイテッドThe Medical College of Wisconsin, Inc. | 全セルフリーdnaによる移植合併症リスクの評価 |
TW202021618A (zh) | 2018-08-17 | 2020-06-16 | 美商23與我有限公司 | 抗il1rap抗體及其使用方法 |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
WO2021236962A1 (fr) | 2020-05-20 | 2021-11-25 | The Medical College Of Wisconsin, Inc. | Compositions et méthodes d'inhibition du syndrôme de libération des cytokines |
CN114835799A (zh) * | 2021-05-28 | 2022-08-02 | 百奥赛图江苏基因生物技术有限公司 | Il1rap基因人源化非人动物的构建方法及应用 |
-
1996
- 1996-01-15 PE PE1996000031A patent/PE64396A1/es not_active Application Discontinuation
- 1996-01-16 ZA ZA96333A patent/ZA96333B/xx unknown
- 1996-01-17 PL PL96321538A patent/PL321538A1/xx unknown
- 1996-01-17 TR TR97/00652T patent/TR199700652T1/xx unknown
- 1996-01-17 EA EA199700265A patent/EA199700265A1/ru unknown
- 1996-01-17 CA CA002210724A patent/CA2210724A1/fr not_active Abandoned
- 1996-01-17 BR BR9606837A patent/BR9606837A/pt unknown
- 1996-01-17 AU AU45370/96A patent/AU4537096A/en not_active Abandoned
- 1996-01-17 IL IL11679696A patent/IL116796A0/xx unknown
- 1996-01-17 EP EP96901291A patent/EP0808365A1/fr not_active Withdrawn
- 1996-01-17 WO PCT/EP1996/000181 patent/WO1996023067A1/fr not_active Application Discontinuation
- 1996-01-17 HU HU9702458A patent/HUP9702458A2/hu unknown
- 1996-01-17 JP JP8522598A patent/JPH10512453A/ja active Pending
- 1996-01-17 MX MX9705501A patent/MX9705501A/es unknown
- 1996-01-17 CZ CZ972081A patent/CZ208197A3/cs unknown
- 1996-01-19 AR ARP960101095A patent/AR003919A1/es unknown
- 1996-01-22 CO CO96002329A patent/CO4480033A1/es unknown
-
1997
- 1997-07-22 FI FI973089A patent/FI973089A0/fi unknown
- 1997-07-23 NO NO973404A patent/NO973404L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9702458A2 (hu) | 1998-04-28 |
JPH10512453A (ja) | 1998-12-02 |
NO973404D0 (no) | 1997-07-23 |
BR9606837A (pt) | 1998-05-26 |
MX9705501A (es) | 1997-10-31 |
PL321538A1 (en) | 1997-12-08 |
CA2210724A1 (fr) | 1996-08-01 |
CO4480033A1 (es) | 1997-07-09 |
NO973404L (no) | 1997-07-23 |
AR003919A1 (es) | 1998-09-30 |
EP0808365A1 (fr) | 1997-11-26 |
WO1996023067A1 (fr) | 1996-08-01 |
CZ208197A3 (en) | 1997-11-12 |
ZA96333B (en) | 1996-07-23 |
IL116796A0 (en) | 1996-05-14 |
FI973089A (fi) | 1997-07-22 |
PE64396A1 (es) | 1997-01-28 |
TR199700652T1 (xx) | 1998-02-21 |
FI973089A0 (fi) | 1997-07-22 |
AU4537096A (en) | 1996-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199700265A1 (ru) | Добавочный протеин рецептора интерлейкина-1 человека | |
ES2177632T3 (es) | Purificacion de anticuerpos. | |
DE69029015T2 (de) | Antikörper gegen menschlichen Interleukin-6-Rezeptor | |
DE69319662T2 (de) | Monoklonale Antikörper gegen GP130-Protein | |
PT941121E (pt) | Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais | |
DK0643608T3 (da) | Proteinrensning | |
FI963101A (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
RU94045826A (ru) | Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i | |
IT1207589B (it) | Composizione di anticorpi monoclonali umani cross-protettivi. | |
PT840620E (pt) | Antagonistas de il-8 para o tratamento de asma | |
IT1231727B (it) | Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone. | |
DE3684625D1 (de) | Peptidverbindung und durch diese verbindung hergestelltes antiserum. | |
EA199900842A1 (ru) | Модуляторы функции рецепторов, принадлежащих к семейству рецепторов tnf/ngf | |
DK361282A (da) | Fremgangsmaade til fremstilling af o-alkyl-o-carbamoylglycerophosphocholiner | |
OA07609A (fr) | Nouveaux dérivés de la benzylcarbamoylpiridine. | |
FR2765214B1 (fr) | Traitement de granulat par un latex anti-desenrobage | |
DE3687542T2 (de) | Monoklonaler antikoerper gegen humanes protein c. | |
EA199801011A1 (ru) | Моноклональное антитело против человеческого мр52 | |
DE69532611D1 (de) | Mittel zur behandlung von autoimmunkrankheiten | |
ITMI911872A1 (it) | Procedimento per la regolazione lambda di un motore endotermico con catalizzatore. | |
RU94026276A (ru) | Рецепторы интерлейкина-12 и антител | |
KR970040608U (ko) | 엔진의 egr 통로구조 | |
BG48881A1 (en) | Hybridomic cell line mus musculus h 5/9, secretizing monoclonal antibodies against rickettsia conorii | |
KR970041224U (ko) | 엔진용 피스톤의 피스톤링 고정 구조 |